KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 127 filers reported holding KYMERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,100,603 | -37.2% | 870,547 | +3.9% | 0.00% | -50.0% |
| Q2 2023 | $19,270,497 | -51.3% | 838,212 | -37.2% | 0.00% | 0.0% |
| Q1 2023 | $39,547,230 | +87.3% | 1,334,702 | +57.8% | 0.00% | 0.0% |
| Q4 2022 | $21,117,312 | +197.8% | 846,046 | +159.8% | 0.00% | +100.0% |
| Q3 2022 | $7,090,000 | +3.8% | 325,686 | -6.1% | 0.00% | 0.0% |
| Q2 2022 | $6,828,000 | -91.6% | 346,784 | -82.0% | 0.00% | -85.7% |
| Q1 2022 | $81,419,000 | -45.4% | 1,923,889 | -18.0% | 0.01% | -36.4% |
| Q4 2021 | $149,044,000 | +7.7% | 2,347,527 | -0.4% | 0.01% | 0.0% |
| Q3 2021 | $138,380,000 | +30.7% | 2,355,807 | +7.9% | 0.01% | +37.5% |
| Q2 2021 | $105,848,000 | +15.8% | 2,182,429 | -7.2% | 0.01% | 0.0% |
| Q1 2021 | $91,411,000 | -39.6% | 2,352,338 | -3.7% | 0.01% | -38.5% |
| Q4 2020 | $151,408,000 | +107.2% | 2,442,060 | +8.0% | 0.01% | +85.7% |
| Q3 2020 | $73,068,000 | – | 2,261,468 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |